BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1647165)

  • 1. New developments in vaccines.
    Daum RS; Watson B; Clark HF; Plotkin SA
    Adv Pediatr Infect Dis; 1991; 6():1-57. PubMed ID: 1647165
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments in vaccines and immunization practices.
    Casto DT
    Pharmacotherapy; 1992; 12(6 Pt 2):94S-103S. PubMed ID: 1480505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for Haemophilus influenzae type b as models for an otitis vaccine.
    Mäkelä PH; Käyhty H; Peltola H; Eskola J
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S73-5. PubMed ID: 2648298
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of new vaccines in immunization programs.
    Koplan JP
    Isr J Med Sci; 1986; 22(3-4):272-6. PubMed ID: 2943694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(15):296-8. PubMed ID: 8479415
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemophilus influenzae type b vaccine.
    Anderson P; Pichichero ME
    Pediatrics; 1989 Jan; 83(1):145-6. PubMed ID: 2909967
    [No Abstract]   [Full Text] [Related]  

  • 9. [New vaccines].
    Ozişik A; Ustaçelebi S
    Mikrobiyol Bul; 1992 Jan; 26(1):82-9. PubMed ID: 1574025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis.
    Wenger JD; Ward JI; Broome CV
    Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698
    [No Abstract]   [Full Text] [Related]  

  • 11. AAFP, AAP and ACIP release new childhood immunization schedule.
    Am Fam Physician; 1996 Jan; 53(1):395-6. PubMed ID: 8546057
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
    Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
    Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae type b vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jan; 36(50-51):832. PubMed ID: 3121998
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conjugated vaccines against Haemophilus influenzae type b].
    Rümke HC; Poolman JT
    Ned Tijdschr Geneeskd; 1991 Jan; 135(1):4-7. PubMed ID: 2012643
    [No Abstract]   [Full Text] [Related]  

  • 15. Statement on Haemophilus influenzae type b polysaccharide vaccine.
    CMAJ; 1986 Jun; 134(12):1375-6. PubMed ID: 3486707
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.
    Gupta RK; Anderson R; Cecchini D; Rost B; Griffin P; Benscoter K; Xu J; Montanez-Ortiz L; Siber GR
    Dev Biol Stand; 1996; 86():283-96. PubMed ID: 8785957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated Haemophilus influenzae type b vaccine.
    Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA Committee recommends combined DTP, Haemophilus influenzae vaccine.
    Marwick C
    JAMA; 1992 Dec 23-30; 268(24):3415. PubMed ID: 1334159
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
    Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.